NHS refuses to pay up for cancer drug.
OVARIAN cancer patients are being denied a "world first drug" on the NHS, a top scientist claims.
Olaparib treats women with the disease and those with the BRCA cancer gene but is too expensive, claims NHS advisory body Nice.
The drug kicks off a process that leads to the death of cancerous cells.
Prof Paul Workman, of the Institute of Cancer Research, said: "I'd urge Nice to make the drug available."
But Nice chief Sir Andrew Dillon said it was "uncertain" it could extend life.
It could reconsider for women who have had at least three chemo courses.
Angelina Jolie had her ovaries removed in a preven tive op after discovering she had the BRCA cancer gene.